He-Ping Kan, M.D., Fang-lei Wu, M.M., Yong-zhong Wang, M.D., Wen-bin Guo, M.M., Jing-ping Li, M.M., Yu-qi Huang, M.D., Shu-guang Li, M.D., Jian-ping Liu, M.D.
Volume 99, Issue 3, Pages 690-696, 1 March 2013
To study the null of GSTM1, GSTT1 or GSTT1-GSTM1 and the risk of male infertility.
Meta-analysis using electronic database (Pubmed, Medline, Embase, and China National Knowledge Infrastructure) up to August 22, 2011.
The strength of the relationship between null of GSTM1, GSTT1or GSTT1-GSTM1 and the risk of male infertility were assessed by Odds Ratio (ORs). A total of 16 studies were identified in this meta-analysis. (Among the 16 studies, 15 studies reported GSTM1null, 10 GSTT1 and 5 GSTM1-GSTT1).
Meta-analyses by means of random-effects models and fixed-effects models.
Main outcome measure(s):
Ratio of male infertility.
The studies provided overall ORs estimates for GSTM1, GSTT1 and GSTM1-GSTT1, leading to a pooled OR of 1.41 (95% confidence interval (CI), 1.10 -1.81), 1.15 (95% (CI), 0.95–1.39), 2.99(95% (CI), 2.14 -4.18), respectively.
There were evidences that the null of GSTM1 and GSTM1- GSTT1 increasing the risk of male infertility, but GSTT1. We still need further multicentres and better-controlled studies to confirm these findings.
Read the full text at: http://www.fertstert.org/article/S0015-0282(12)02349-7/fulltext